Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 22:00:00
Hyperfine Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
1,11 1,83 0,02 383 228
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiHyperfine Inc
TickerHYPR
Kmenové akcie:Ordinary Shares Class A
Kmenové akcie:Ordinary Shares CLass B
RICHYPR.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.06.2025
Počet zaměstnanců k 15.03.2025 111
Akcie v oběhu k 01.08.2025 78 581 001
MěnaUSD
Kontaktní informace
Ulice351 New Whitfield Street
MěstoGUILFORD
PSČ06437
ZeměUnited States
Kontatní osobaWebb Campbell
Funkce kontaktní osobyInvestor Relations
Fax13026365454

Business Summary: Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Hyperfine Inc revenues decreased 30% to $4.8M. Net loss decreased 7% to $18.6M. Revenues reflect DEVICE segment decrease of 36% to $3.7M, SERVICE segment decrease of 6% to $1.2M. Lower net loss reflects Research and development - Balancing decrease of 18% to $8.9M (expense), Stock-based Compensation in SGA decrease of 57% to $580K (expense).
Odvětvová klasifikace
TRBC2012Medical Imaging Systems
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSComputing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
NAICS2007Electromedical Apparatus Mfg
NAICS2007Data Processing, Hosting, and Related Services
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Data Processing Services
SICElectromedical Equipment
SICData Processing And Preparation



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorMaria Sainz5924.10.202224.10.2022
Chief Financial Officer, Chief Administrative Officer, Chief Compliance Officer, Treasurer, Corporate SecretaryBrett Hale5113.02.2023
Chief Operating OfficerThomas Teisseyre4124.07.2023